GLUTATHIONE levels are decreased in the substantia nigra of patients w
ith Parkinson's disease. We studied whether glutathione depletion cont
ributes to dopaminergic cell death using a specific inhibitor of gluta
thione biosynthesis, L-buthionine sulfoximine (BSO). We found no. sign
ificant reduction of tyrosine hydroxylase-positive cells in the substa
ntia nigra pars compacta (SNpc) when BSO was administered systemically
to preweanling mice or locally to the SNpc of adult rats. However, th
e combination of BSO with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropy
ridine) in preweanling mice and the combination of nigral injections o
f BSO with intrastriatal injections of MPP+ (1-methyl-4-phenylpyridini
um), the active metabolite of MPTP in adult rats, potentiated the toxi
c effects of MPTP and MPP+ on nigral neurones. Our data show that glut
athione depletion can result in cell death if the nigrostriatal system
is metabolically compromised.